RPAM
Rhenman & Partners Asset Management Portfolio holdings
AUM
$791M
This Quarter Return
+4.99%
1 Year Return
+12.81%
3 Year Return
+98.32%
5 Year Return
+175.58%
10 Year Return
+579.5%
AUM
$707M
AUM Growth
+$707M
(+26%)
Cap. Flow
+$106M
Cap. Flow
% of AUM
15.03%
Top 10 Holdings %
Top 10 Hldgs %
27.95%
Holding
103
New
12
Increased
42
Reduced
34
Closed
6
Top Buys
| 1 |
Johnson & Johnson
JNJ
|
$18.6M |
| 2 |
UnitedHealth
UNH
|
$12.3M |
| 3 |
Cooper Companies
COO
|
$7.3M |
| 4 |
ESRX
Express Scripts Holding Company
ESRX
|
$7.03M |
| 5 |
Medtronic
MDT
|
$6.36M |
Top Sells
| 1 |
Amgen
AMGN
|
$4.61M |
| 2 |
OCR
OMNICARE INC
OCR
|
$3.85M |
| 3 |
Gilead Sciences
GILD
|
$3.4M |
| 4 |
Universal Health Services
UHS
|
$3.13M |
| 5 |
Ligand Pharmaceuticals
LGND
|
$3.01M |
Sector Composition
| 1 | Healthcare | 90.66% |
| 2 | Financials | 0.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Myriad Genetics
MYGN
$633M
| – | – |
-60,000
| Closed | -$2.12M |
|
|
102
Ligand Pharmaceuticals
LGND
$3.25B
| – | – |
-39,000
| Closed | -$3.01M |
|